feed,title,long_url,short_url
BioRxiv,Drug repurposing screen identifies masitinib as a 3CLpro inhibitor that blocks replication of SARS-CoV-2 in vitro,https://biorxiv.org/cgi/content/short/2020.08.31.274639v1?rss=1,https://j.mp/34U0wbX
BioRxiv,Characterization of neutralizing versus binding antibodies and memory B cells in COVID-19 recovered individuals from India,https://biorxiv.org/cgi/content/short/2020.08.31.276675v1?rss=1,https://j.mp/3jC04mI
